Blake Belanger

Statistics

Publications

Citations

245

H-Index

Active since

1997

Affiliations

Bristol-Myers Squibb (United States)(Current)

Blake Belanger is an author at Bristol-Myers Squibb (United States) specializing in molecular biology, signal transactivation, and acute myeloid leukemia therapy.

Publications per year

1997–2012

Publications

BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis <i>In Vitro</i> and Shows Antitumor Activity <i>In Vivo</i> in Hematologic Malignancies

Michelle Kuhne, Tanya Mulvey, Blake Belanger et al. · Clinical Cancer Research · 2012 · 208 citations

Medicine, Hematology, Oncology +17

Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.

Fawzi Aoudjit, Nancy Brochu, Blake Belanger et al. · PubMed · 1997 · 37 citations

Life Sciences, Immunology, Molecular Biology +13

1–2 of 2